Perseus Proteomics Inc
TSE:4882

Watchlist Manager
Perseus Proteomics Inc Logo
Perseus Proteomics Inc
TSE:4882
Watchlist
Price: 230 JPY -2.95% Market Closed
Market Cap: 3.4B JPY

Wall Street
Price Targets

Price Targets Summary
Perseus Proteomics Inc

Wall Street analysts forecast Perseus Proteomics Inc stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for Perseus Proteomics Inc is 765 JPY with a low forecast of 757.5 JPY and a high forecast of 787.5 JPY.

Lowest
Price Target
757.5 JPY
229% Upside
Average
Price Target
765 JPY
233% Upside
Highest
Price Target
787.5 JPY
242% Upside
Perseus Proteomics Inc Competitors:
Price Targets
CSL
CSL Ltd
40% Upside
URGN
Urogen Pharma Ltd
69% Upside
KRYS
Krystal Biotech Inc
13% Downside
XFOR
X4 Pharmaceuticals Inc
104% Upside
ATX
Amplia Therapeutics Ltd
145% Upside
BMRN
Biomarin Pharmaceutical Inc
56% Upside
9926
Akeso Inc
36% Upside

Revenue
Forecast

Revenue Estimate
Perseus Proteomics Inc

For the last 6 years the compound annual growth rate for Perseus Proteomics Inc's revenue is -13%. The projected CAGR for the next 3 years is 95%.

-13%
Past Growth
95%
Estimated Growth
Estimates Accuracy
1%
Average Beat

Operating Income
Forecast

Operating Income Estimate
Perseus Proteomics Inc

Operating Income forecast
is not available for
Perseus Proteomics Inc

Net Income
Forecast

Net Income Estimate
Perseus Proteomics Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-24%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is Perseus Proteomics Inc's stock price target?
Price Target
765 JPY

According to Wall Street analysts, the average 1-year price target for Perseus Proteomics Inc is 765 JPY with a low forecast of 757.5 JPY and a high forecast of 787.5 JPY.

What is Perseus Proteomics Inc's Revenue forecast?
Projected CAGR
95%

For the last 6 years the compound annual growth rate for Perseus Proteomics Inc's revenue is -13%. The projected CAGR for the next 3 years is 95%.

Back to Top